What matters to you.

Forum Network

Free online lectures: Explore a world of ideas

Funding provided by:

Exploring the Current Debate Over Patenting Life (Part 1)

In partnership with:
Date and time
Friday, January 28, 2011

Panel one of this symposium examines the intersection of patents, bioethics, and economics: Can or should we patent life? The symposium addresses the ongoing legal debate that surrounds patents on potentially therapeutic biomedical technologies, including gene patents. The symposium considers how other disciplines, including bioethics and economics, might help to inform the development of novel laws addressing the unique issues arising from the debate. The symposium includes a lecture discussing the role patents have played in spurring the innovation of adult stem cell-based therapies, as well as a presentation on genetic testing and the impact patents have had on patient access to new biomedical technologies.

Hassan Naqvi is part of the Licensing group at Cleveland Clinic Innovations, and is responsible for the evaluation, protection and commercialization of biotechnology innovations across multiple specialties. He manages an extensive portfolio of technologies in the molecular biology space, working closely with the Clinic’s Genomic Medicine Institute and the Pathology and Laboratory Medicine Institute. Mr. Naqvi also oversees license compliance and enforcement issues for CC Innovations. He is an active member of the Association of University Technology Managers, a national professional society of technology licensing professionals. Mr. Naqvi earned his PhD in Cell and Molecular biology from the University of Texas at Austin in 2007, with a focus on Immunology. His post doctoral investigations into the feasibility of utilizing algae lipids as a fuel source led to the formation of OFAT, a Joint Venture between the University of Texas at Austin and Organic Fuels Inc., of Houston, Texas. In addition, he worked with a small chemical company developing novel fluorescent indicators for measuring calcium and sodium levels in living cells.
Craig A. Nard is the Tom J.E. and Bette Lou Walker Professor of Law and the founding director of the Center for Law, Technology and the Arts. He is also a Senior Lecturer at the World Intellectual Property Organization Academy at the University of Torino, Italy, and Principal Advisor to the Center for Studies and Research in Intellectual Property in Calcutta, India. Prof. Nard practiced intellectual property law in Dallas, Texas prior to becoming the Julius Silver Fellow in Law, Science, and Technology at Columbia University School of Law. After his fellowship, he clerked on the United States Court of Appeals for the Federal Circuit in Washington, D.C. for the Honorable Helen W. Nies, and then the Honorable Giles S. Rich. Prof. Nard has published in various law reviews, including the Northwestern Law Review, Georgetown Law Journal, Minnesota Law Review, Illinois Law Review, Indiana Law Journal, Harvard Journal of Law & Technology, Review of Law & Economics, William & Mary Law Review, and the Wake Forest Law Review. He is also the author of the patent law casebook, The Law of Patents (Aspen Publishers 2008), Fundamentals of United States Intellectual Property Law, (Kluwer Law International 2006) (with Halpern and Port) and The Law of Intellectual Property (Aspen Publishing) (2005) (with Madison and Barnes). Craig served as member of the Northern District of California Advisory Committee on Model Patent Jury Instructions appointed by the Honorable Ronald M. Whyte of the Northern District of California. He is licensed to practice before the Patent and Trademark Office and is a member of the Texas bar. He teaches in the areas of patent law and intellectual property. Prof. Nard received his B.A. in from Washington & Jefferson (1987), his J.D. from Capital (1990), and his LL.M. from Columbia (1995). Bratislav Stankovic,
Dr. Bratislav Stankovic strives to foster improved understanding of the issues at the intersection of law, science, politics, and ethics through a variety of means, including traditional publications, as well as providing input to government and international organizations. He has made particular contributions in the areas of international property rights and plant space biology, and in policy issues involving biotechnology. He holds a PhD degree in Biological Sciences from the University of Nebraska‐Lincoln, and a JD degree from the University of Wisconsin‐Madison. Dr. Stankovic is a registered patent attorney. He is admitted to practice law in Illinois and in Wisconsin, is a Professor of Law at the University American College Skopje, teaches Patent Law at Loyola University Chicago, and has practiced at one of the largest IP law firms in the USA, Brinks Hofer Gilson & Lione in Chicago. He is a Science and Technology Advisor to the President of Macedonia Dr. Gjorge Ivanov. He is a recipient of two Fulbright Scholarships for Intellectual Property Law. Dr. Stankovic writes and teaches on patent law, biotechnology law, bioethics, law and medicine, molecular and space biology. He also has over 20 years of experience as a scientist, including 4 years as a Chief Scientist at the NASA‐funded Wisconsin Center for Space Automation and Robotics, University of Wisconsin‐Madison, where he was the principal investigator for several experiments on the Space Shuttle and the International Space Station.
Joseph Jankowski, Ph.D. is Case Western Reserve University Associate Vice President, Technology Management. He leads the commercialization efforts that stem from the $300+ million of annual research activity taking place at the university and its institutional affiliates. He is dedicated to Case Western Reserve University’s translational activities and holds leadership roles on the Coulter-Case Translation and Innovation Partnership, the Ohio BRCP Targeted Nanoparticles Center and the SOM High Throughput Screening Committee. In addition, Dr. Jankowski represents the university on the Outside Interests Committee, the Ohio Technology Transfer Officers’ Council, and the University Hospitals Case Medical Center Research Committee. He also serves on the boards of several Case Western Reserve University spinoff companies. In 2006, Dr. Jankowski joined the university faculty, teaching intellectual property commercialization and entrepreneurship in the schools of business, engineering, law and medicine. He holds a Ph.D. in chemistry from SUNY College of Environmental Sciences, an M.B.A. from Case Western Reserve University’s Weatherhead School of Management, and a B.S. in engineering technologies from the University of Dayton.